KLF15通过PPARδ减轻脂多糖诱导的肾小管上皮细胞凋亡和炎症反应
该研究在脂多糖(LPS)诱导的HK2细胞脓毒症损伤模型中,转染KLF15过表达质粒,用CCK-8法测细胞活力、流式细胞术测凋亡、ELISA测炎症因子、蛋白质印迹测KLF15、PPARδ及炎症和凋亡相关蛋白,并用免疫沉淀和数据库确认KLF15与PPARδ的相互作用,再用PPARδ激动剂和小干扰RNA验证机制。结果显示LPS诱导的HK2细胞KLF15和PPARδ表达下调、活力下降,凋亡及TNFα、IL-1β、IL-6水平升高;过表达KLF15、过表达PPARδ或给予PPARδ激动剂可减轻上述改变,而干扰PPARδ会减弱Ov-KLF15的保护作用。结论为KLF15通过PPARδ减轻LPS诱导的HK2细胞凋亡和炎症反应。
要点
- LPS诱导的HK2细胞中KLF15和PPARδ表达下调,细胞活力下降,凋亡及TNFα、IL-1β、IL-6水平升高。
- 过表达KLF15、过表达PPARδ或给予PPARδ激动剂均可减轻LPS诱导的HK2细胞上述凋亡和炎症改变。
- 干扰PPARδ可显著减弱Ov-KLF15对HK2细胞的保护作用,提示KLF15的保护作用依赖PPARδ。
- 免疫沉淀实验显示KLF15与PPARδ在HK2细胞中可能存在相互作用。
- LPS上调HK2细胞Bax、胞质细胞色素C、Cox-2和p-NF-κB-p65表达,同时下调Bcl2和线粒体细胞色素C表达。
适用人群与场景
- 体外培养的HK2人肾小管上皮细胞,用于模拟脓毒症相关急性肾损伤的细胞模型。
研究设计与关键结果
- 研究类型为体外细胞实验,在HK2细胞中通过给予脂多糖(LPS)建立脓毒症损伤模型,并转染KLF15过表达质粒。
- LPS诱导的HK2细胞显示KLF15和PPARδ表达下调,细胞活力下降,凋亡及TNFα、IL-1β、IL-6水平升高。
- LPS上调HK2细胞Bax、胞质细胞色素C、Cox-2和p-NF-κB-p65表达,同时下调Bcl2和线粒体细胞色素C表达。
- 免疫沉淀实验显示KLF15与PPARδ在HK2细胞中可能存在相互作用。
- 过表达KLF15、过表达PPARδ或给予PPARδ激动剂可有效减轻LPS诱导的上述改变;干扰PPARδ可显著减弱Ov-KLF15对HK2细胞的保护作用。
证据类型、等级与局限
- 证据类型:体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: The kidney is the most commonly affected organ in sepsis patients, and Krüppel-like transcription factor 15 (KLF15) has a kidney-protective effect and is highly enriched in the kidneys. This study aims to explore the role of KLF15 in sepsis-related acute kidney injury. Methods: A septic injury model in HK2 cells was established through the administration of lipopolysaccharide (LPS), followed by the transfection of an overexpression plasmid for KLF15. Cell viability was assessed using Cell Counting Kit-8 assay, and apoptosis was measured via flow cytometry. The levels of inflammatory cytokines were detected using ELISA, and western blot assay was employed to assess the expression of KLF15, PPARδ, as well as inflammatory and apoptosis-related proteins. The interaction between KLF15 and PPARδ was confirmed through the utilization of online databases and immunoprecipitation experiments. The mechanism was further validated using PPARδ agonists and small interfering RNA. Results: LPS-induced HK2 cells showed downregulated expression of KLF15 and PPARδ, along with decreased viability, accompanied by increased levels of apoptosis, TNFα, IL-1β, and IL-6. Additionally, LPS upregulated the expression of Bax, cytoplasmic cytochrome C [Cytc (cyt)], Cox-2, and p-NF-κB-p65 in HK2 cells, while simultaneously downregulating the expression of Bcl2 and mitochondrial cytochrome c [Cytc (mit)]. immunoprecipitation experiment revealed a possible interaction between KLF15 and PPARδ in HK2 cells. Ov-KLF15, Ov-PPARδ, or administration of PPARδ agonists effectively alleviated the aforementioned alterations induced by LPS. However, interference with PPARδ significantly attenuated the protective effect of Ov-KLF15 on HK2 cells. Conclusion: KLF15 attenuates LPS-induced apoptosis and inflammatory responses in HK2 cells via PPARδ.
参考来源
- Shao Y, Li X, Zhou W, et al. KLF15 ATTENUATES LIPOPOLYSACCHARIDE-INDUCED APOPTOSIS AND INFLAMMATORY RESPONSE IN RENAL TUBULAR EPITHELIAL CELLS VIA PPARΔ. Shock. 2024. PMID: 39227395. doi:10.1097/SHK.0000000000002431
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。